Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Coronary Artery Disease: later-stage trial registry
57 of 220 indexed Coronary Artery Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #42 of 28,707 conditions by registered trial count.
220 US clinical trials · 57 currently recruiting · #42 of 28,707 conditions by registered trial count
Coronary Artery Disease: 220 US clinical trials tracked, 57 recruiting.
Coronary Artery Disease is the subject of 220 registered US clinical trials on ClinicalTrials.gov, 57 of them currently open to new participants. 42 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is University of Florida, running 17 of these trials.
Enrollment posture brief
Registry condition coronary-artery-disease
OPEN 57 | RECR 26% | LATE 42 | EARLY 15 | RANK #42 | SPON 17
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma (26% recruiting · 27 trials)
Coronary Artery Disease lists 57 open slots (26% of 220 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Coronary Artery Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Coronary Artery Disease is recruiting below its size-band peers.
57 of 220 indexed trials (25.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Coronary Artery Disease trials is spread across many organizations.
University of Florida accounts for 17 of 220 trials (7.7%). 134 distinct sponsors appear on at least one study for this condition label.
-
Typical Coronary Artery Disease enrolment sits around 266 participants.
Median target enrolment is 266 among the 220 trials that report a genuine target (sentinel values excluded). 70 of those (31.8%) plan for fewer than 100 participants.
-
Coronary Artery Disease splits between interventional and observational designs.
153 interventional and 67 observational studies make up this index (69.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
220 total, page 4 of 5
Comparing TR Band to Statseal in Conjunction With TR Band
VA Long Beach Healthcare System
NCT03028025
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
Johns Hopkins University
NCT00353795
Evaluation Using Computed Tomography Angiography (CTA) to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)
Corewell Health East
NCT00580008
Sapphire 3 CTO Study
OrbusNeich
NCT06358508
Familiarization and Safety Study of PB127 Ultrasound Contrast Agent
Point Biomedical
NCT00594698
Stress CT Perfusion in Patients With Chest Pain
University of Chicago
NCT01969916
Left Versus Right Radial Artery and Radiation Exposure in Patients With Predictors of Trans-radial Failure
NYU Langone Health
NCT01707524
Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)
Shockwave Medical
NCT05966662
Effect of Evolocumab on Coronary Plaque Characteristics
Annapoorna Kini
NCT04710368
Age and Endothelial Progenitor Cell Mobilization
Emory University
NCT00585949
Cardiovascular Outcomes Of Diet Counseling
The Camelot Foundation
NCT00324545
Secondary Prevention After Coronary Bypass Surgery
Jeffrey Kramer, MD
NCT00843089
Myocardial Ischemia and Transfusion Pilot
Rutgers, The State University of New Jersey
NCT01167582
Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
Marc Sakwa, MD
NCT01681095
Abbott Next Generation Drug Eluting Stent 48mm Study
Abbott Medical Devices
NCT04282148
Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
University of Florida
NCT04484259
Rapid Stress/Rest Single-Day Tc-99m Sestamibi Myocardial Single Photon Emission Computed Tomography
St. Luke's-Roosevelt Hospital Center
NCT01434641
Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB
Baylor Research Institute
NCT01083914
Vegan vs AHA Diet on Inflammation and Glucometabolic Profile in Patients With CAD
NYU Langone Health
NCT02135939
Vitamin D Repletion in Coronary Artery Disease
Seth I. Sokol, M.D.
NCT01570309
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
Boston Scientific Corporation
NCT01498692
AngioSculpt® Coronary Bifurcation Study
AngioScore
NCT00686647
Aspirin Resistance in Coronary Artery Disease
Vanderbilt University
NCT00753935
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Annapoorna Kini
NCT01567826
Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease
University of Florida
NCT02287909
Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease
Johns Hopkins University
NCT04272060
Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention
Wake Forest University Health Sciences
NCT06647238
HCR vs. CABG Study
Emory University
NCT02892474
Observational Study of the Association Between Periodontal Disease and Cardiovascular Disease
Texas Tech University Health Sciences Center
NCT02177591
Reducing Radioisotope Dose: the Half-Dose CZT Study
S.M.Chang, MD
NCT01518777
Side Branch FFR After Provisional Stenting
Icahn School of Medicine at Mount Sinai
NCT03115580
Quantification of Myocardial Blood Flow Using Dynamic PET/CTA Fused Imagery
Emory University
NCT04221594
Prasugrel Re-load Strategies
University of Florida
NCT01201772
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
Maine Center for Lipids and Cardiovascular Health
NCT00360217
Expression of Angiogenic Factors in Myocardial Tissue
University of Virginia
NCT01414621
Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery
Corewell Health West
NCT03604432
Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride
Kathirvel Subramaniam
NCT03270514
A Behavioral Science-Enhanced PHysician-led Remote Group Exercise InTervention for Women With Coronary Artery Disease
Brigham and Women's Hospital
NCT05611333
Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI
Emory University
NCT00166179
Effect of Ile-Pro-Pro (IPP) on Endothelial Function in Patients With Coronary Artery Disease
Boston University
NCT00924157
Effects of Almonds On Endothelial Function In Patients With Coronary Artery Disease
Boston University
NCT01038362
High Ticagrelor Loading Dose in STEMI
University of Florida
NCT01898442
HemoSonics-UVA HemoSonics-UVA Cardiac Surgery Clinical Study Protocol
University of Virginia
NCT02456467
To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease
MedImmune
NCT02601560
Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia
St. Louis University
NCT01161121
Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation
Mayo Clinic
NCT04992676
18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques
Cedars-Sinai Medical Center
NCT02607748
VasoStat vs. TR Band for Radial Hemostasis
Forge Medical
NCT04163471
Platelet Sub-study of the TWILIGHT Trial
Juan Badimon
NCT04001374
Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
University of Florida
NCT03437044
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 9 |
| Phase 3 | 17 |
| Phase 4 | 25 |
Top Sponsors
Named interventions
Most-linked intervention names on Coronary Artery Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Coronary Artery Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Coronary Artery Disease page
220 registered trials, 57 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 57 Coronary Artery Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Florida sponsors the most Coronary Artery Disease trials on record, review their full trial history before evaluating a specific study. See University of Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronary Artery Disease condition card totals 220 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.